Mineralys Therapeutics, Inc.

MLYS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $2.4B · 76 employees
65
SEC Filings
$25.61
Close 2026-06-23
76
Employees

Business Summary

Part I Business Overview We are a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that we are developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities such as chronic kidney disease (CKD) and obstructive sleep apnea (OSA...

Latest Stock Quote

MLYS 2026-06-23 $25.61 O:$25.03 H:$26.3 L:$24.55 Vol:1.4M VWAP:$25.7196
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001933414-26-000056EDGAR77K words
2025-02-122024-12-310001933414-25-000009EDGAR
2024-03-212023-12-310001628280-24-012358EDGAR
2023-03-152022-12-310001933414-23-000012EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001933414-25-000142EDGAR21K words
2025-08-122025-06-300001933414-25-000090EDGAR
2025-05-122025-03-310001933414-25-000058EDGAR
2024-11-122024-09-300001933414-24-000057EDGAR
2024-08-132024-06-300001933414-24-000039EDGAR
2024-05-092024-03-310001933414-24-000016EDGAR
2023-11-072023-09-300001933414-23-000087EDGAR
2023-08-072023-06-300001933414-23-000056EDGAR
2023-05-152023-03-310001933414-23-000038EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001933414-26-000054EDGAR2K words
2026-03-090001933414-26-000048EDGAR
2026-01-060001933414-26-000002EDGAR
2025-11-100001933414-25-000139EDGAR
2025-09-030001933414-25-000120EDGAR
2025-09-020001933414-25-000107EDGAR
2025-08-120001933414-25-000088EDGAR
2025-06-170001933414-25-000070EDGAR
2025-05-220001933414-25-000064EDGAR
2025-05-120001933414-25-000057EDGAR

65 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK0001933414
TickerMLYS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://mineralystx.com
Listed2023-02-10

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 69240d9bd7d8dc86baa67f7a20dbe948c7a7a22c6b196825bf973141467c979c
parent: 6f238ac2b0576787be83831867d2cb40c4199e2f924e39cc11ebf2ed60b8dde8
content hash: fd155d4c7a6172948185dfbe2934682ebbdfd1371983524ef4c6fb02b68244a6
signed: 2026-08-11T19:05:23.981Z
sources: 13 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MLYS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MLYS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MLYS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.